Clinical Trial

STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2022 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
STARflo is a novel suprachoroidal Glaucoma Drainage Device (GDD), bleb-free, exhibiting anti-fibrotic properties. Release of this CE Marked implant has been limited to leading Glaucoma Centers in Europe.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2016-07-06; most recent amendment 2022-08-08.
Status change: Recruiting → Active, Not Recruiting 2019-11-14
Status change: Not Yet Recruiting → Recruiting 2017-10-16
Trial Details
NCT Number NCT02825264
Lead Sponsor iSTAR Medical
Conditions Open Angle Glaucoma
Enrollment 70 participants
Start Date 2016-07
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2022-08-09